Shape-controlled silver and palladium nanoparticles were for the first time synthesized by seed-mediated techniques in the presence of β-cyclodextrin (β-CD). Palladium and silver seeds were prepared by reduction of palladium or silver ions with sodium borohydride in the presence of sodium citrate dihydrate as a stabilizer. Seeds were then injected into a “growth” solution containing the same Pd (or Ag) precursor, ascorbic acid (as a weak reducing agent), and β-CD. Using β-cyclodextrin impacts the final morphology of silver nanoparticles through a strong capping effect slowing down the growth regime and shifting it to thermodynamic-controlled conditions. Adjusting the β-CD/Ag molar ratio can lead to the selective formation of multiply twinned icosahedral particles presenting mainly {111} facets. On palladium, β-cyclodextrin selectively led to the controlled aggregation of primary nanoparticles into nanodendrites or multipods. After deposition on TiO 2, these nanostructured Pd catalysts show excellent activity for the hydrogenation of cinnamaldehyde.
No takes yet. Share an insight, caveat, or question.
Kochkar et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: